CVRx, Inc. Comprehensive Income
CVRx, Inc. (CVRX) reported Comprehensive Income of -$14.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$14.04M.
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$13.12M.
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$11.93M.
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$12.87M.
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$53.30M.
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$59.96M.
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$41.20M.
- CVRx, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$41.44M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.04M 10-Q · filed 2026-08-06 | -$27.16M 10-Q · filed 2026-08-06 | -$39.10M derived: sum of 3 quarters · filed 2026-08-06 | -$51.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$13.12M 10-Q · filed 2026-05-12 | -$25.05M derived: sum of 2 quarters · filed 2026-05-12 | -$37.92M derived: sum of 3 quarters · filed 2026-05-12 | -$52.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$11.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$24.80M derived: sum of 2 quarters · filed 2026-02-13 | -$39.54M derived: sum of 3 quarters · filed 2026-08-06 | -$53.30M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$12.87M 10-Q · filed 2025-11-06 | -$27.60M derived: sum of 2 quarters · filed 2026-08-06 | -$41.37M 10-Q · filed 2025-11-06 | -$52.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$14.73M 10-Q · filed 2026-08-06 | -$28.50M 10-Q · filed 2026-08-06 | -$39.15M derived: sum of 3 quarters · filed 2026-08-06 | -$52.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$13.77M 10-Q · filed 2026-05-12 | -$24.41M derived: sum of 2 quarters · filed 2026-05-12 | -$37.51M derived: sum of 3 quarters · filed 2026-05-12 | -$51.54M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$10.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$23.75M derived: sum of 2 quarters · filed 2026-02-13 | -$37.77M derived: sum of 3 quarters · filed 2026-02-13 | -$59.96M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$13.10M 10-Q · filed 2025-11-06 | -$27.13M derived: sum of 2 quarters · filed 2025-11-06 | -$49.31M 10-Q · filed 2025-11-06 | -$58.48M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$14.03M 10-Q · filed 2025-08-05 | -$36.22M 10-Q · filed 2025-08-05 | -$45.38M derived: sum of 3 quarters · filed 2025-08-05 | -$54.41M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$22.19M 10-Q · filed 2025-05-09 | -$31.35M derived: sum of 2 quarters · filed 2025-05-09 | -$40.38M derived: sum of 3 quarters · filed 2025-05-09 | -$52.02M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$9.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$18.19M derived: sum of 2 quarters · filed 2025-02-18 | -$29.83M derived: sum of 3 quarters · filed 2025-02-18 | -$41.20M 10-K · filed 2025-02-18 |
| 2023-09-30 | -$9.03M 10-Q · filed 2024-11-01 | -$20.67M derived: sum of 2 quarters · filed 2024-11-01 | -$32.04M 10-Q · filed 2024-11-01 | -$42.56M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$11.63M 10-Q · filed 2024-08-02 | -$23.00M 10-Q · filed 2024-08-02 | -$33.53M derived: sum of 3 quarters · filed 2024-08-02 | -$43.37M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$11.37M 10-Q · filed 2024-05-10 | -$21.89M derived: sum of 2 quarters · filed 2024-05-10 | -$31.73M derived: sum of 3 quarters · filed 2024-05-10 | -$42.81M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | -$20.36M derived: sum of 2 quarters · filed 2024-02-09 | -$31.44M derived: sum of 3 quarters · filed 2024-02-09 | -$41.44M 10-K · filed 2024-02-09 |
| 2022-09-30 | -$9.84M 10-Q · filed 2023-10-31 | -$20.92M derived: sum of 2 quarters · filed 2023-10-31 | -$30.91M 10-Q · filed 2023-10-31 | -$41.48M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | -$11.08M 10-Q · filed 2023-08-03 | -$21.07M 10-Q · filed 2023-08-03 | -$31.64M derived: sum of 3 quarters · filed 2023-08-03 | -$37.78M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$10.00M 10-Q · filed 2023-05-11 | -$20.57M derived: sum of 2 quarters · filed 2023-05-11 | -$26.70M derived: sum of 3 quarters · filed 2023-05-11 | -$44.45M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$10.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$16.71M derived: sum of 2 quarters · filed 2023-02-10 | -$34.45M derived: sum of 3 quarters · filed 2023-02-10 | -$43.09M 10-K · filed 2023-02-10 |
| 2021-09-30 | -$6.14M 10-Q · filed 2022-11-04 | -$23.89M derived: sum of 2 quarters · filed 2022-11-04 | -$32.52M 10-Q · filed 2022-11-04 | -$35.91M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$17.75M 10-Q · filed 2022-08-01 | -$26.38M 10-Q · filed 2022-08-01 | -$29.78M derived: sum of 3 quarters · filed 2022-08-01 | -$32.99M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | -$8.63M 10-Q · filed 2022-05-02 | -$12.03M derived: sum of 2 quarters · filed 2022-05-02 | -$15.24M derived: sum of 3 quarters · filed 2022-05-02 | -$18.92M derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | -$3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$6.61M derived: sum of 2 quarters · filed 2022-02-22 | -$10.29M derived: sum of 3 quarters · filed 2022-02-22 | -$14.11M 10-K · filed 2022-02-22 |
| 2020-09-30 | -$3.21M 10-Q · filed 2021-11-08 | -$6.89M derived: sum of 2 quarters · filed 2021-11-08 | -$10.71M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$3.68M 10-Q · filed 2021-08-09 | -$7.50M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |